Protection against the Omicron Variant from Previous SARS-CoV-2 Infection

N Engl J Med. 2022 Mar 31;386(13):1288-1290. doi: 10.1056/NEJMc2200133. Epub 2022 Feb 9.

Authors

Heba N Altarawneh¹, Hiam Chemaitelly¹, Mohammad R Hasan², Houssein H Ayoub³, Suelen Qassim¹, Sawsan AlMukdad¹, Peter Coyle⁴, Hadi M Yassine³, Hebah A Al-Khatib³, Fatiha M Benslimane³, Zaina Al-Kanaani⁴, Einas Al-Kuwari⁴, Andrew Jeremijenko⁴, Anvar H Kaleeckal⁴, Ali N Latif⁴, Riyazuddin M Shaik⁴, Hanan F Abdul-Rahim³, Gheyath K Nasrallah³, Mohamed G Al-Kuwari⁵, Adeel A Butt⁴, Hamad E Al-Romaihi⁶, Mohamed H Al-Thani⁶, Abdullatif Al-Khal⁴, Roberto Bertollini⁶, Patrick Tang², Laith J Abu-Raddad⁷

Affiliations

¹ Weill Cornell Medicine-Qatar, Doha, Qatar.
² Sidra Medicine, Doha, Qatar.
³ Qatar University, Doha, Qatar.
⁴ Hamad Medical Corporation, Doha, Qatar.
⁵ Primary Health Care, Doha, Qatar.
⁶ Ministry of Public Health, Doha, Qatar.
⁷ Weill Cornell Medicine-Qatar, Doha, Qatar lja2002@qatar-med.cornell.edu.

No abstract available

Publication types

Letter

MeSH terms

Adaptive Immunity* / immunology
COVID-19* / immunology
COVID-19* / virology
Humans
SARS-CoV-2 / genetics
SARS-CoV-2 / immunology

Supplementary concepts

SARS-CoV-2 variants